학술논문
CANbridge Announces Marketing Approval of CAN108 (Mai Rui Bei (r)|LIVMARLI(r)) in China for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome
Document Type
News
Author
Source
Plus Company Updates. June 5, 2023
Subject
Language
English
Abstract
BEIJING: CANbridge Pharmaceuticals Inc. has issued the following news release: CANbridge Pharmaceuticals, Inc. (1228.HK), a global biopharmaceutical company, with a foundation in China, committed to the research, development and commercialization [...]